Development of new tuberculosis vaccines: a global perspective on regulatory issues.
Brennan
Michael J
MJ
Office of Vaccines Research and Review, Center for Biologics Evaluation and Research, Food and Drug Administration, Rockville, Maryland, United States of America. Michael.Brennan@fda.hhs.gov
Fruth
Uli
U
Milstien
Julie
J
Tiernan
Rosemary
R
de Andrade Nishioka
Sergio
S
Chocarro
Liliana
L
D002986:Clinical Trials as Topic / Q000331:legislation & jurisprudence*; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D014943:Global Health; D006801:Humans; D009169:Mycobacterium tuberculosis / Q000276:immunology; D011640:Public Policy; D014376:Tuberculosis / Q000276:immunology / Q000382:microbiology / Q000517:prevention & control* / Q000635:transmission; D032581:Tuberculosis Vaccines / Q000276:immunology / Q000592:standards
D032581:Tuberculosis Vaccines